SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001172661-20-000221
Filing Date
2020-01-17
Accepted
2020-01-17 16:04:39
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G HOLDINGS REPORT AMENDMENT arp-achn011020a1.htm SC 13G/A 79618
  Complete submission text file 0001172661-20-000221.txt   81187
Mailing Address 300 GEORGE STREET NEW HAVEN CT 06511
Business Address 300 GEORGE STREET NEW HAVEN CT 06511 203-624-7000
ACHILLION PHARMACEUTICALS INC (Subject) CIK: 0001070336 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-82163 | Film No.: 20533588
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1120 AVENUE OF THE AMERICAS 15 FL NEW YORK NY 10036
Business Address 1120 AVENUE OF THE AMERICAS 15 FL NEW YORK NY 10036 212.626.6508
ARP AMERICAS LP (Filed by) CIK: 0001650301 (see all company filings)

IRS No.: 464720267 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13G/A